Michael Haimerl1, Irene Fuhrmann2, Stefanie Poelsterl2, Claudia Fellner2, Marcel D Nickel3, Kilian Weigand4, Marc H Dahlke5, Niklas Verloh2, Christian Stroszczynski2, Philipp Wiggermann2. 1. Department of Radiology, University Hospital Regensburg, 93042, Regensburg, Germany. michael.haimerl@ukr.de. 2. Department of Radiology, University Hospital Regensburg, 93042, Regensburg, Germany. 3. MR Applications Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany. 4. Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany. 5. Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Abstract
OBJECTIVES: To determine whether liver function as determined by intravenous administration of 13C-methacetin and continuous real-time breath analysis can be estimated quantitatively from gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) relaxometry. METHODS: Sixty-six patients underwent a 13C-methacetin breath test (13C-MBT) for evaluation of liver function and Gd-EOB-DTPA-enhanced T1-relaxometry at 3 T. A transverse 3D VIBE sequence with an inline T1 calculation based on variable flip angles was acquired prior to (T1 pre) and 20 min post-Gd-EOB-DTPA (T1 post) administration. The reduction rate of T1 relaxation time (rrT1) and T1 relaxation velocity index (∆R1) between pre- and post-contrast images was evaluated. 13C-MBT values were correlated with T1post, ∆R1 and rrT1, providing an MRI-based estimated 13C-MBT value. The interobserver reliability was assessed by determining the intraclass correlation coefficient (ICC). RESULTS: Stratified by three different categories of 13C-MBT readouts, there was a constant increase of T1 post with increasing progression of diminished liver function (p ≤ 0.030) and a constant significant decrease of ∆R1 (p ≤ 0.025) and rrT1 (p < 0.018) with progression of liver damage as assessed by 13C-methacetin breath analysis. ICC for all T1 relaxation values and indices was excellent (> 0.88). A simple regression model showed a log-linear correlation of 13C-MBT values with T1post (r = 0.57; p < 0.001), ∆R1 (r = 0.59; p < 0.001) and rrT1 (r = 0.70; p < 0.001). CONCLUSION: Liver function as determined using real-time 13C-methacetin breath analysis can be estimated quantitatively from Gd-EOB-DTPA-enhanced MR relaxometry. KEY POINTS: • Gd-EOB-DTPA-enhanced T1 relaxometry quantifies liver function • Gd-EOB-DTPA-enhanced MR relaxometry may provide parameters for assessing liver function before surgery • Gd-EOB-DTPA-enhanced MR relaxometry may be useful for monitoring liver disease progression • Gd-EOB-DTPA-enhanced MR relaxometry has the potential to become a novel liver function index.
OBJECTIVES: To determine whether liver function as determined by intravenous administration of 13C-methacetin and continuous real-time breath analysis can be estimated quantitatively from gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) relaxometry. METHODS: Sixty-six patients underwent a 13C-methacetin breath test (13C-MBT) for evaluation of liver function and Gd-EOB-DTPA-enhanced T1-relaxometry at 3 T. A transverse 3D VIBE sequence with an inline T1 calculation based on variable flip angles was acquired prior to (T1 pre) and 20 min post-Gd-EOB-DTPA (T1 post) administration. The reduction rate of T1 relaxation time (rrT1) and T1 relaxation velocity index (∆R1) between pre- and post-contrast images was evaluated. 13C-MBT values were correlated with T1post, ∆R1 and rrT1, providing an MRI-based estimated 13C-MBT value. The interobserver reliability was assessed by determining the intraclass correlation coefficient (ICC). RESULTS: Stratified by three different categories of 13C-MBT readouts, there was a constant increase of T1 post with increasing progression of diminished liver function (p ≤ 0.030) and a constant significant decrease of ∆R1 (p ≤ 0.025) and rrT1 (p < 0.018) with progression of liver damage as assessed by 13C-methacetin breath analysis. ICC for all T1 relaxation values and indices was excellent (> 0.88). A simple regression model showed a log-linear correlation of 13C-MBT values with T1post (r = 0.57; p < 0.001), ∆R1 (r = 0.59; p < 0.001) and rrT1 (r = 0.70; p < 0.001). CONCLUSION: Liver function as determined using real-time 13C-methacetin breath analysis can be estimated quantitatively from Gd-EOB-DTPA-enhanced MR relaxometry. KEY POINTS: • Gd-EOB-DTPA-enhanced T1 relaxometry quantifies liver function • Gd-EOB-DTPA-enhanced MR relaxometry may provide parameters for assessing liver function before surgery • Gd-EOB-DTPA-enhanced MR relaxometry may be useful for monitoring liver disease progression • Gd-EOB-DTPA-enhanced MR relaxometry has the potential to become a novel liver function index.
Entities:
Keywords:
Breath test; Contrast media; Liver diseases; Liver function tests; Magnetic resonance imaging
Authors: O Dahlqvist Leinhard; N Dahlström; J Kihlberg; P Sandström; T B Brismar; O Smedby; P Lundberg Journal: Eur Radiol Date: 2011-10-09 Impact factor: 5.315
Authors: Wilmar de Graaf; Stephanie Häusler; Michal Heger; Tessa M van Ginhoven; Gert van Cappellen; Roelof J Bennink; Gerd A Kullak-Ublick; Rolf Hesselmann; Thomas M van Gulik; Bruno Stieger Journal: J Hepatol Date: 2010-10-01 Impact factor: 25.083
Authors: Maximilian Jara; Tim Reese; Maciej Malinowski; Erika Valle; Daniel Seehofer; Gero Puhl; Peter Neuhaus; Johann Pratschke; Martin Stockmann Journal: HPB (Oxford) Date: 2015-07 Impact factor: 3.647
Authors: Li Wang; Carol Collins; Edward J Kelly; Xiaoyan Chu; Adrian S Ray; Laurent Salphati; Guangqing Xiao; Caroline Lee; Yurong Lai; Mingxiang Liao; Anita Mathias; Raymond Evers; William Humphreys; Cornelis E C A Hop; Sean C Kumer; Jashvant D Unadkat Journal: Drug Metab Dispos Date: 2016-08-19 Impact factor: 3.922
Authors: Michael Haimerl; Niklas Verloh; Florian Zeman; Claudia Fellner; René Müller-Wille; Andreas G Schreyer; Christian Stroszczynski; Philipp Wiggermann Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240
Authors: F Rassam; T Zhang; K P Cieslak; C Lavini; J Stoker; R J Bennink; T M van Gulik; L J van Vliet; J H Runge; F M Vos Journal: Eur Radiol Date: 2019-02-22 Impact factor: 5.315
Authors: Lucian Beer; Mattias Mandorfer; Nina Bastati; Sarah Poetter-Lang; Dietmar Tamandl; Dilyana Plamenova Stoyanova; Michael Christoph Elmer; Georg Semmler; Benedikt Simbrunner; Jacqueline C Hodge; Claude B Sirlin; Thomas Reiberger; Ahmed Ba-Ssalamah Journal: Eur Radiol Date: 2019-04-18 Impact factor: 5.315
Authors: Carolina Río Bártulos; Karin Senk; Mona Schumacher; Jan Plath; Nico Kaiser; Ragnar Bade; Jan Woetzel; Philipp Wiggermann Journal: Front Med (Lausanne) Date: 2022-04-06